Pharmaceutical From Standard to Specialist Capsule Formats Hard gelatin, HPMC, inhalation and vaginal formats engineered for every therapeutic need.
Nutraceutical Consumer-Ready Nutraceutical Formats Capsules and branded ingredients built for supplement manufacturers who demand differentiation.
Pharmaceutical CDMO
Accelerating Drug Development
Our Innovaform Accelerator and Tampa facility combine formulation science with scalable manufacturing.
CDMO Partnership
Full-Service Nutraceutical Manufacturing
From concept to market-ready product — your end-to-end nutraceutical development partner.
Our Story
Partners in Drug Delivery Innovation
A global leader in capsule technologies, committed to advancing pharmaceutical and nutraceutical science.
Biological therapies have transformed the treatment of chronic and complex diseases, yet their impact is often limited by the need for parenteral administration. Oral delivery of biologics represents a major opportunity to improve patient experience, adherence, and healthcare efficiency, but achieving it has historically been constrained by poor stability and low bioavailability of the API in the gastrointestinal (GI) tract.
Today, advances in formulation science are redefining what’s possible. While biologics are frequently associated with large, complex molecules such as monoclonal antibodies , the category spans a broad range of modalities, including smaller peptides like GLP-1 receptor agonists that are well suited to oral approaches. Emerging strategies across enteric protection, permeation enhancement, lipid-based formulations, and novel delivery devices are beginning to overcome long-standing biochemical and physiological barriers.
Download the whitepaper to explore the scientific challenges, enabling technologies, and real-world examples shaping the future of oral biologic delivery , and learn how innovative formulation strategies are opening new pathways to clinical and commercial success.
Latest CHI content
